Oncological patients often require intensive care unit (ICU) admission during the diagnosis and treatment process. Accurate determination of indications is crucial to maintain a balance between patient benefits and potential harms and ensure rational utilization of ICU beds. In our ICU, we primarily care for oncological patients. Our aim is to collect data on solid organ tumor patients discharged from the ICU, with a focus on assessing their survival chances and the continuity of post-discharge treatment.